Abstract
In the United States, the annual incidence of malignant pancreatic neoplasm is estimated at 37 170 cases, with 33 370 deaths each year.1 These numbers confirm the lethality of this disease. Pancreatic resection is necessary for cure or long-term survival. Only 10% to 20% of patients will have resectable tumors at initial presentation, and only 10% to 20% of patients who undergo resection will survive 5 years.2

This publication has 26 references indexed in Scilit: